RISK OF INCIDENT HEPATOCELLULAR CARCINOMA (HCC) IN CHRONIC HEPATITIS B (CHB) VIRUS-INFECTED PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF) VERSUS ENTECAVIR (ETV): A US ADMINISTRATIVE CLAIMS ANALYSIS

被引：1
|
作者：
Kim, Ray [1 ]
Telep, Laura [2 ]
Lu, Mei [3 ]
Ramroth, Heribert [2 ]
Flaherty, John [2 ]
Gaggar, Anuj [2 ]
Chokkalingam, Anand [2 ]
Chan, Carol Yee Kwan [2 ]
Gordon, Stuart [3 ]
机构：
[1] Stanford Univ, Palo Alto, CA 94304 USA
[2] Gilead Sci, Foster City, CA USA
[3] Henry Ford Hlth Syst, Detroit, MI USA
来源：
GUT | 2020年 / 69卷
关键词：
D O I：
10.1136/gutjnl-2020-IDDF.140
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
IDDF2020-A
引用
收藏
页码：A73 / A73
页数：1
相关论文
共 50 条
  • [1] RISK OF INCIDENT HEPATOCELLULAR CARCINOMA IN HEPATITIS B-INFECTED PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE VERSUS ENTECAVIR: A US ADMINISTRATIVE CLAIMS ANALYSIS
    Kim, W. Ray
    Telep, Laura
    Lu, Mei
    Ramroth, Heribert
    Flaherty, John F.
    Gaggar, Anuj
    Chokkalingam, Anand
    Gordon, Stuart C.
    [J]. HEPATOLOGY, 2019, 70 : 302A - 303A
  • [2] Risk and risk factors of hepatocellular carcinoma (HCC) in Caucasian chronic hepatitis B (CHB) patients with or without cirrhosis treated with entecavir (ETV) or tenofovir (TDF)
    Papatheodoridis, George V.
    Dalekos, George N.
    Yurdaydin, Cihan
    Goulis, Ioannis
    Arends, Pauline
    Buti, Maria
    Sypsa, Vana
    Manolakopoulos, Spilios
    Mangia, Giampaolo
    Gatselis, Nikolaos
    Keskin, Onur
    Savvidou, Savvoula
    Hansen, Bettina E.
    Papaioannou, Christos
    Galanis, Kostas
    Idilman, Ramazan
    Colombo, Massimo
    Esteban, Rafael
    Janssen, Harry L.
    Lampertico, Pietro
    [J]. HEPATOLOGY, 2013, 58 : 302A - 303A
  • [3] ALT Levels and Risk of Hepatocellular Carcinoma (HCC) in Caucasian Chronic Hepatitis B (CHB) Patients Under Long-Term Therapy with Entecavir (ETV) or Tenofovir Disoproxil Fumarate (TDF)
    Papatheodoridis, George V.
    Dalekos, George N.
    Yurdaydin, Cihan
    Sypsa, Vana
    van Bommel, Florian
    Buti, Maria
    Luis Calleja, Jose
    Chi, Heng
    Goulis, Ioannis
    Manolakopoulos, Spilios
    Loglio, Alessandro
    Siakavellas, Spyros
    Keskin, Onur
    Veelken, Rhea
    Lopez-Gomez, Marta
    Hansen, Bettina E.
    Savvidou, Savvoula
    Kourikou, Anastasia
    Vlachogiannakos, Ioannis
    Galanis, Kostas
    Idilman, Ramazan
    Esteban, Rafael
    Janssen, Harry L. A.
    Berg, Thomas
    Lampertico, Pietro
    [J]. HEPATOLOGY, 2018, 68 : 162A - 163A
  • [4] SIMILAR RISK OF HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT DURING LONG-TERM ENTECAVIR (ETV) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) THERAPY IN CAUCASIAN CHRONIC HEPATITIS B (CHB) PATIENTS
    Papatheodoridis, George V.
    Dalekos, George N.
    Yurdaydin, Cihan
    Sypsa, Vana
    van Boemmel, Florian
    Buti, Maria
    Luis Calleja, Jose
    Goulis, Ioannis
    Manolakopoulos, Spilios
    Loglio, Alessandro
    Papatheodoridi, Margarita
    Gatselis, Nikolaos K.
    Keskin, Onur
    Veelken, Rhea
    Lopez Gomez, Marta
    Hansen, Bettina E.
    Savvidou, Savvoula
    Kourikou, Anastasia
    Vlachogiannakos, Jiannis
    Galanis, Kostas
    Idilman, Ramazan
    Esteban-Mur, Rafael
    Janssen, Harry L. A.
    Berg, Thomas
    Lampertico, Pietro
    [J]. HEPATOLOGY, 2019, 70 : 286A - 287A
  • [5] Outcomes and characteristics of hepatocellular carcinomas (HCC) in Caucasian chronic hepatitis B (CHB) patients treated with long-term entecavir (ETV) or tenofovir disoproxil fumarate (TDF) therapy
    Papatheodoridis, George
    Dalekos, George
    Idilman, Ramazan
    Sypsa, Vana
    Buti, Maria
    Calleja Panero, Jose Luis
    Goulis, Ioannis
    Sonneveld, Milan
    van Bommel, Florian
    Manolakopoulos, Spilios
    Loglio, Alessandro
    Papatheodoridi, Margarita
    Gatselis, Nikolaos
    Lopez-Gomez, Marta
    Savvidou, Savvoula
    Brakenhoff, Sylvia
    Samakidou, Anna
    Yurdaydin, Cihan
    Esteban, Rafael
    Janssen, Harry
    Berg, Thomas
    Lampertico, Pietro
    [J]. JOURNAL OF HEPATOLOGY, 2021, 75 : S747 - S748
  • [6] IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)
    Chan, Henry Lik Yuen
    Lim, Young-Suk
    Seto, Wai Kay
    Ning, Qin
    Agarwal, Kosh
    Janssen, Harry L. A.
    Pan, Calvin O.
    Chuang, Wan Long
    Izumi, Namiki
    Fung, Scott
    Shalimar
    Brunetto, Maurizia
    Flaherty, John
    Mo, Shuyuan
    Cheng, Cong
    Lin, Lanjia
    Gaggar, Anuj
    Subramanian, Mani
    Marcellin, Patrick
    Gane, Edward
    Hou, Jinlin
    Buti, Maria
    [J]. GUT, 2020, 69 : A75 - A76
  • [7] IMPACT OF TREATMENT WITH TENOFOVIR ALAFENAMIDE (TAF) OR TENOFOVIR DISOPROXIL FUMARATE (TDF) ON HEPATOCELLULAR CARCINOMA (HCC) INCIDENCE IN PATIENTS WITH CHRONIC HEPATITIS B (CHB)
    Lim, Young-Suk
    Chan, Henry Lik Yuen
    Seto, Wai-Kay
    Ning, Qing
    Agarwal, Kosh
    Janssen, Harry L. A.
    Pan, Calvin Q.
    Chuang, Wan Long
    Izumi, Namiki
    Fung, Scott K.
    Shalimar
    Brunetto, Maurizia R.
    Flaherty, John F.
    Mo, Shuyuan
    Cheng, Cong
    Lin, Lanjia
    Gaggar, Anuj
    Subramanian, Mani
    Marcellin, Patrick
    Gane, Edward J.
    Hou, Jinlin
    Buti, Maria
    [J]. HEPATOLOGY, 2019, 70 : 126A - 127A
  • [8] PAGE-B: RISK SCORE FOR HEPATOCELLULAR CARCINOMA (HCC) DEVELOPMENT IN CAUCASIAN CHRONIC HEPATITIS B (CHB) PATIENTS RECEIVING ENTECAVIR (ETV) OR TENOFOVIR (TDF)
    Papatheodoridis, G. V.
    Dalekos, G.
    Sypsa, V.
    Yurdaydin, C.
    Buti, M.
    Goulis, J.
    Arends, P.
    Manolakopoulos, S.
    Mangia, G.
    Gatselis, N.
    Keskin, O.
    Savvidou, S.
    Hansen, B. E.
    Papaioannou, C.
    Galanis, K.
    Idilman, R.
    Colombo, M.
    Esteban, R.
    Janssen, H. L. A.
    Lampertico, P.
    [J]. JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S435 - S435
  • [9] Timing of hepatocellular carcinoma (HCC) development and predictability of a modified PAGE-B risk score in caucasian chronic hepatitis B (CHB) patients treated with entecavir (ETV) or tenofovir (TDF)
    Papatheodoridis, George V.
    Dalekos, George N.
    Sypsa, Vana
    Yurdaydin, Cihan
    Buti, Maria
    Goulis, Ioannis
    Chi, Heng
    Manolakopoulos, Spilios
    Mangia, Giampaolo
    Gatselis, Nikolaos
    Keskin, Onur
    Savvidou, Savvoula
    Hansen, Bettina E.
    Vlachogiannakos, Jiannis
    Galanis, Kostas
    Idilman, Ramazan
    Colombo, Massimo
    Esteban, Rafael
    Janssen, Harry L.
    Lampertico, Pietro
    [J]. HEPATOLOGY, 2014, 60 : 316A - 317A
  • [10] The risk of hepatocellular carcinoma (HCC) is decreasing after the first 5 years of entecavir (ETV) or tenofovir (TDF) therapy in Caucasian chronic hepatitis B (CHB) patients
    Papatheodoridis, George V.
    Yurdaydin, Cihan
    Dalekos, George N.
    Buti, Maria
    Chi, Heng
    van Boemmel, Florian
    Calleja, Jose L.
    Sypsa, Vana
    Goulis, Ioannis
    Manolakopoulos, Spilios
    Loglio, Alessandro
    Siakavellas, Spyros I.
    Keskin, Onur
    Gatselis, Nikolaos
    Hansen, Bettina E.
    Lehretz, Maria
    de la Revilla, Juan
    Savvidou, Savvoula
    Kourikou, Anastasia
    Vlachogiannakos, Jiannis
    Idilman, Ramazan
    Galanis, Kostas
    Berg, Thomas
    Colombo, Massimo
    Esteban, Rafael
    Janssen, Harry L.
    Lampertico, Pietro
    [J]. HEPATOLOGY, 2016, 64 : 923A - 923A
12345